Firazyr
Active Ingredient(s): Icatibant AcetateFDA Approved: * August 25, 2011
Pharm Company: * SHIRE ORPHAN THERAPIES
Category: Immune System
Icatibant, sold under the brand name Firazyr, is a medication for the symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults with C1-esterase-inhibitor deficiency.[4][2][3] It is not effective in angioedema caused by medication from the ACE inhibitor class.[5] It is a peptidomimetic consisting of ten amino acids, which is a selective and specific antagonist of bradykinin B2 receptors. Contents 1 Mechani... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.